|
|
|
| Webinar: From First-in-Human to Proof-of-Concept — Quicker, Smarter, Streamlined | Unlock the keys to successful First-in-Human studies with Quotient. This webinar reveals how expert-designed SAD/MAD trials, flexible CMC strategies, and smart regulatory planning accelerate proof-of-concept while avoiding costly setbacks. Gain insider insights on biomarkers, patient recruitment, and data integration—plus real-world case studies across rare diseases, obesity, CNS, and inflammation. De-risk early development and keep your program moving forward. Click here to learn more. |
|
|
|
|
Lower Punch Tip Bending And Buckling | Article | Natoli Engineering Company, Inc. | When manufacturing mini-tablets, adjusting punch force ratings is crucial to prevent bending or buckling. The Rankine-Gordon formula offers a safer force rating for microtip tooling. |
|
|
|
|
By Louis Garguilo, chief editor, Outsourced Pharma | The radiopharmaceuticals industry is benefiting from increasing investments and a rush of promising innovation. At the same time, it faces a rather spotty outsourcing services and supply infrastructure. The Radiopharmaceutical Blueprint Report calls this the industry’s central paradox, “a multi-billion-dollar wave of investment and commercial validation is colliding with a fragile, underdeveloped infrastructure” of isotope supply, GMP manufacturing, and talent. | |
|
|
Advice For Managing Multiple CDMOs | By Outsourced Pharma Live | We all look to simplify the supply chain. Unfortunately, simple (or even consolidated) isn't always possible. You are left with the heavy task of managing multiple CDMOs across a supply chain. At a recent Outsourced Pharma Live digital discussion, we learned how. |
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
Nanoformed API: A Superior Alternative To Solid Dispersions | Article | By Dr. Tamas Solymosi, Nanoform | Cutting-edge nanotechnology is now emerging, able to address bioavailability challenges and deliver higher drug loads in more patient-friendly formats with fewer and smaller pills and easier regimens. |
|
|
|
|
|
|
| Join 1,000+ pharma, biotech, and drug delivery professionals at the PODD: Partnership Opportunities in Drug Delivery Conference, October 27–28 in Boston. Featuring 10 technology tracks, pharma company spotlights, 1:1 partnering, and more. Attendees will also hear from leaders at companies including AbbVie, Amgen, AstraZeneca, Biogen, Eli Lilly, GSK, Moderna, Novartis, Pfizer, Regeneron, Roche, Sanofi, Takeda, and others. Register at PODDConference.com with code LSL20 for 20% off. |
|
|
|
Fill/Finish Capabilities Update January 2025 | Jubilant HollisterStier | From early development through small-scale production to global commercialization, our experience with international agencies underscores our ability to navigate complex requirements with precision. |
|
|
|
|
OUTSOURCED PHARMA CAPACITY UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
Connect With Outsourced Pharma: |
|
|
|